Ana Belén Sanz Bartolomé-rekin lankidetzan egindako argitalpenak (7)

2020

  1. Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy

    International Journal of Molecular Sciences, Vol. 21, Núm. 11

2019

  1. Diabetes-mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction

    Molecular Oncology, Vol. 13, Núm. 9, pp. 1887-1897

  2. Molecular evidence of field cancerization initiated by diabetes in colon cancer patients

    Molecular Oncology, Vol. 13, Núm. 4, pp. 857-872

2018

  1. Targeting inflammation in diabetic nephropathy: a tale of hope

    Expert Opinion on Investigational Drugs, Vol. 27, Núm. 11, pp. 917-930

2017

  1. 2017 update on the relationship between diabetes and colorectal cancer: Epidemiology, potential molecular mechanisms and therapeutic implications

    Oncotarget, Vol. 8, Núm. 11, pp. 18456-18485

  2. Atrasentan for the treatment of diabetic nephropathy

    Expert Opinion on Investigational Drugs, Vol. 26, Núm. 6, pp. 741-750

  3. Colon cancer modulation by a diabetic environment: A single institutional experience

    PLoS ONE, Vol. 12, Núm. 3